[시장보고서]의료용 전기 및 전기 치료 기구 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

의료용 전기 및 전기 치료 기구 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Electro-medical And Electrotherapeutic Apparatus Market Size, Share & Trends Analysis Report By Product (Diagnostic, Therapeutic), By Application (Cardiology, Oncology), By End Use, By Region, And Segment Forecasts, 2025 - 2030

상품코드 : 1611075

리서치사 : Grand View Research

발행일 : 2024년 11월

페이지 정보 : 영문 200 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,521,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 9,953,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 12,818,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

의료용 전기 및 전기 치료 기구 시장 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면, 세계 의료용 전기 및 전기 치료 기구 시장 규모는 2030년까지 955억 달러에 달할 것으로 예상되며, 2025-2030년 연평균 6.4%의 성장률을 기록할 것으로 예측됩니다. 시장 성장을 촉진하는 주요 요인으로는 고령 인구 증가, 기술 발전, 진단 및 치료 옵션에 대한 환자 인식 증가, 다양한 만성질환의 유병률 증가 등이 있습니다. 예를 들어, 국제암연구소는 2022년 전 세계적으로 약 1,997만 6,499명의 신규 암 환자와 974만 3,832명의 암 관련 사망자가 발생할 것으로 예상했습니다.

암, 심혈관질환, 신경 질환과 같은 만성질환의 유병률이 증가함에 따라 효과적인 진단 및 치료 솔루션에 대한 필요성이 증가하고 있습니다. 전기 의료기기 및 전기 치료 장비는 정확한 진단을 지원하고, 환자의 상태를 모니터링하고, 치료법을 제공하는 효율적이고 진보된 장비를 제공함으로써 이러한 요구에 부응하는 데 중요한 역할을 하고 있습니다. 이러한 기기는 환자의 결과를 개선하고 만성질환을 보다 효과적으로 관리하기 위해 필수적입니다. 기술 발전은 전체 시장 성장에 기여할 것으로 예상됩니다. 예를 들어, 2024년 4월 비침습적 뇌 자극 및 보완적 모니터링 기술의 세계 리더인 소테릭스 메디컬(Soterix Medical Inc.)은 MxN-GO EEG의 출시를 발표했습니다. 이 혁신적인 시스템은 고화질 경두개 전기자극(HD-tES)과 뇌파를 결합한 것으로, 끈이 필요 없는 독특한 디자인이 특징입니다.

M&A, 제품 출시, 규제 당국의 승인, 제휴, 공동 연구, R&D, 사업 확장 등 주요 시장 진입자들의 전략적 노력은 시장 성장을 촉진하는 데 필수적입니다. 예를 들어, 2024년 7월 세계 의료 기술 선도기업인 필립스는 푸네의 스타 이미징(Star Imaging)과 제휴하여 인도 최초의 MRI 교육 학교를 설립할 것이라고 발표했습니다. 이 기관은 17개 세부 분야에 걸쳐 국제적으로 인정받는 MRI 기술 교육을 제공할 예정입니다.

의료용 전기 및 전기 치료 기구 시장 보고서 하이라이트

2024년 진단 부문이 37.9%의 점유율을 차지하며 제품 부문을 독식했습니다.
치료 장비 부문은 예측 기간 동안 가장 빠른 CAGR로 성장할 것으로 예상됩니다.
응용 분야에서는 순환기 부문이 2024년 26.9%의 매출 점유율로 가장 큰 시장 점유율을 차지했습니다.
신경학 부문은 예측 기간 동안 가장 빠른 속도로 성장할 것으로 예상됩니다.
최종 용도 중 병원은 2024년 46.5%의 시장 점유율을 차지했습니다.
외래 수술 센터 부문은 예측 기간 동안 가장 빠른 속도로 성장할 것으로 예상됩니다.
북미가 2024년 47.0%의 점유율을 차지하며 시장을 장악했습니다.

지역별 시장 점유율 분석, 2023년과 2030년
지역별 시장 대시보드
세계 지역 시장 현황
시장 규모, 예측 동향 분석, 2018-2030년
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 노르웨이
- 스웨덴
- 덴마크
아시아태평양
- 일본
- 중국
- 인도
- 호주
- 한국
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트

제8장 경쟁 구도

주요 시장 진출 기업의 최근 동향과 영향 분석
기업/경쟁 분류
주요 기업의 시장 점유율 분석, 2024년
Company Position Analysis
기업 분류(신흥 기업, 이노베이터, 리더)
기업 개요
- GE HealthCare
- Koninklijke Philips NV
- Siemens Healthineers AG
- Medtronic
- Abbott
- Boston Scientific Corporation
- Fujifilm Holdings Corporation
- Zimmer Biomet
- Nihon Kohden Corporation
- OMRON Healthcare, Inc.
- Invacare Corporation

ksm

영문 목차

영문목차

Electro-medical And Electrotherapeutic Apparatus Market Growth & Trends:

The global electro-medical and electrotherapeutic apparatus market size is anticipated to reach USD 95.5 billion by 2030, according to a new report by Grand View Research, Inc. It is projected to grow at a CAGR of 6.4% from 2025 to 2030. Key factors driving market growth include the increasing geriatric population, advancements in technology, rising awareness among patients about diagnostic and treatment options, and the growing prevalence of various chronic disorders. For instance, the International Agency for Research on Cancer reported approximately 19,976,499 new cancer cases and 9,743,832 cancer-related deaths worldwide in 2022.

The growing prevalence of chronic disorders such as cancer, cardiovascular diseases, and neurological conditions necessitates the need for effective diagnostic and treatment solutions. Electro-medical and electrotherapeutic apparatus play a crucial role in addressing this need by offering efficient and advanced devices that support accurate diagnoses, monitor patient conditions, and deliver therapeutic treatments. These devices are essential in improving patient outcomes and managing chronic conditions more effectively. Advancements in technology is further expected to contribute to overall market growth. For instance, in April 2024, Soterix Medical Inc., a global leader in non-invasive brain stimulation and complementary monitoring technologies, announced the launch of the MxN-GO EEG. This innovative system combines High-Definition transcranial Electrical Stimulation (HD-tES) with EEG, featuring a unique untethered design.

Strategic initiatives by key market players, such as mergers and acquisitions, product launches, regulatory approvals, partnerships, collaborations, research and development (R&D) efforts, and expansion, are essential in driving the growth of the market. For example, in July 2024, Philips, a global leader in health technology, announced a partnership with Star Imaging in Pune to establish a first-of-its-kind MRI Training School in India. This institution will offer internationally recognized training on MRI technologies across 17 sub-specialties.

Electro-Medical And Electrotherapeutic Apparatus Market Report Highlights:

In 2024, the diagnostic segment dominated the product segment by capturing a share of 37.9%.
The therapeutic equipment segment is anticipated to grow at the fastest CAGR during the forecast period.
Cardiology segment held the largest market share in the application segment by capturing a revenue share of 26.9% in 2024.
The neurology segment is expected to grow at the fastest rate during the forecast period.
Among end use, hospitals held a majority share of the market of 46.5% in 2024.
The ambulatory surgical centers segment is expected to grow at the fastest rate over the forecast period.
North America dominated the market with a share of 47.0% in 2024.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Application
- 1.2.3. End Use
- 1.2.4. Regional scope
- 1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
  - 1.4.5.1. Data for primary interviews in North America
  - 1.4.5.2. Data for primary interviews in Europe
  - 1.4.5.3. Data for primary interviews in Asia Pacific
  - 1.4.5.4. Data for primary interviews in Latin America
  - 1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Application outlook
- 2.2.3. End use outlook
- 2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Electro-medical and Electrotherapeutic Apparatus Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Increasing prevalence of chronic disorders
  - 3.2.1.2. Growing awareness among public regarding advanced diagnostic and treatment options
  - 3.2.1.3. Rising geriatric population
  - 3.2.1.4. Advancements in technology
- 3.2.2. Market restraint analysis
  - 3.2.2.1. High cost of devices
  - 3.2.2.2. Complex regulatory environment
3.3. Electro-medical and Electrotherapeutic Apparatus Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Supplier power
  - 3.3.1.2. Buyer power
  - 3.3.1.3. Substitution threat
  - 3.3.1.4. Threat of new entrant
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Technological landscape
  - 3.3.2.3. Economic landscape

Chapter 4. Electro-medical and Electrotherapeutic Apparatus Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Global Electro-medical and Electrotherapeutic Apparatus Product Market Movement Analysis
4.3. Global Electro-medical and Electrotherapeutic Apparatus Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Diagnostic Equipment
- 4.4.1. Diagnostic equipment market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Therapeutic Equipment
- 4.5.1. Therapeutic equipment market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Surgical Devices
- 4.6.1. Surgical devices market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Patient Assistive Devices
- 4.7.1. Patient assistive devices market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Others
- 4.8.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Electro-medical and Electrotherapeutic Apparatus Market: Application Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Global Electro-medical and Electrotherapeutic Apparatus Application Market Movement Analysis
5.3. Global Electro-medical and Electrotherapeutic Apparatus Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Cardiology
- 5.4.1. Cardiology market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Neurology
- 5.5.1. Neurology market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Oncology
- 5.6.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Orthopedics
- 5.7.1. Orthopedics market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Gynecology
- 5.8.1. Gynecology market estimates and forecasts 2018 to 2030 (USD Million)
5.9. Urology
- 5.9.1. Urology market estimates and forecasts 2018 to 2030 (USD Million)
5.10. Others
- 5.10.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Electro-medical and Electrotherapeutic Apparatus Market: End Use Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Global Electro-medical and Electrotherapeutic Apparatus End Use Market Movement Analysis
6.3. Global Electro-medical and Electrotherapeutic Apparatus Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Hospitals
- 6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Ambulatory Surgical Centers
- 6.5.1. Ambulatory surgical centers market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Diagnostic Centers
- 6.6.1. Diagnostic centers market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Others
- 6.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Electro-medical and Electrotherapeutic Apparatus Market: Regional Estimates & Trend Analysis By Product, Application, End Use

7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. North America
- 7.5.1. U.S.
  - 7.5.1.1. Key country dynamics
  - 7.5.1.2. Competitive scenario
  - 7.5.1.3. Regulatory framework
  - 7.5.1.4. Reimbursement structure
  - 7.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.2. Canada
  - 7.5.2.1. Key country dynamics
  - 7.5.2.2. Competitive scenario
  - 7.5.2.3. Regulatory framework
  - 7.5.2.4. Reimbursement structure
  - 7.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.3. Mexico
  - 7.5.3.1. Key country dynamics
  - 7.5.3.2. Competitive scenario
  - 7.5.3.3. Regulatory framework
  - 7.5.3.4. Reimbursement structure
  - 7.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Europe
- 7.6.1. UK
  - 7.6.1.1. Key country dynamics
  - 7.6.1.2. Competitive scenario
  - 7.6.1.3. Regulatory framework
  - 7.6.1.4. Reimbursement structure
  - 7.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.2. Germany
  - 7.6.2.1. Key country dynamics
  - 7.6.2.2. Competitive scenario
  - 7.6.2.3. Regulatory framework
  - 7.6.2.4. Reimbursement structure
  - 7.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.3. France
  - 7.6.3.1. Key country dynamics
  - 7.6.3.2. Competitive scenario
  - 7.6.3.3. Regulatory framework
  - 7.6.3.4. Reimbursement structure
  - 7.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.4. Italy
  - 7.6.4.1. Key country dynamics
  - 7.6.4.2. Competitive scenario
  - 7.6.4.3. Regulatory framework
  - 7.6.4.4. Reimbursement structure
  - 7.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.5. Spain
  - 7.6.5.1. Key country dynamics
  - 7.6.5.2. Competitive scenario
  - 7.6.5.3. Regulatory framework
  - 7.6.5.4. Reimbursement structure
  - 7.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.6. Norway
  - 7.6.6.1. Key country dynamics
  - 7.6.6.2. Competitive scenario
  - 7.6.6.3. Regulatory framework
  - 7.6.6.4. Reimbursement structure
  - 7.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.7. Sweden
  - 7.6.7.1. Key country dynamics
  - 7.6.7.2. Competitive scenario
  - 7.6.7.3. Regulatory framework
  - 7.6.7.4. Reimbursement structure
  - 7.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.8. Denmark
  - 7.6.8.1. Key country dynamics
  - 7.6.8.2. Competitive scenario
  - 7.6.8.3. Regulatory framework
  - 7.6.8.4. Reimbursement structure
  - 7.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Asia Pacific
- 7.7.1. Japan
  - 7.7.1.1. Key country dynamics
  - 7.7.1.2. Competitive scenario
  - 7.7.1.3. Regulatory framework
  - 7.7.1.4. Reimbursement structure
  - 7.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.2. China
  - 7.7.2.1. Key country dynamics
  - 7.7.2.2. Competitive scenario
  - 7.7.2.3. Regulatory framework
  - 7.7.2.4. Reimbursement structure
  - 7.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.3. India
  - 7.7.3.1. Key country dynamics
  - 7.7.3.2. Competitive scenario
  - 7.7.3.3. Regulatory framework
  - 7.7.3.4. Reimbursement structure
  - 7.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.4. Australia
  - 7.7.4.1. Key country dynamics
  - 7.7.4.2. Competitive scenario
  - 7.7.4.3. Regulatory framework
  - 7.7.4.4. Reimbursement structure
  - 7.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.5. South Korea
  - 7.7.5.1. Key country dynamics
  - 7.7.5.2. Competitive scenario
  - 7.7.5.3. Regulatory framework
  - 7.7.5.4. Reimbursement structure
  - 7.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.6. Thailand
  - 7.7.6.1. Key country dynamics
  - 7.7.6.2. Competitive scenario
  - 7.7.6.3. Regulatory framework
  - 7.7.6.4. Reimbursement structure
  - 7.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.8. Latin America
- 7.8.1. Brazil
  - 7.8.1.1. Key country dynamics
  - 7.8.1.2. Competitive scenario
  - 7.8.1.3. Regulatory framework
  - 7.8.1.4. Reimbursement structure
  - 7.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.2. Argentina
  - 7.8.2.1. Key country dynamics
  - 7.8.2.2. Competitive scenario
  - 7.8.2.3. Regulatory framework
  - 7.8.2.4. Reimbursement structure
  - 7.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.9. MEA
- 7.9.1. South Africa
  - 7.9.1.1. Key country dynamics
  - 7.9.1.2. Competitive scenario
  - 7.9.1.3. Regulatory framework
  - 7.9.1.4. Reimbursement structure
  - 7.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.2. Saudi Arabia
  - 7.9.2.1. Key country dynamics
  - 7.9.2.2. Competitive scenario
  - 7.9.2.3. Regulatory framework
  - 7.9.2.4. Reimbursement structure
  - 7.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.3. UAE
  - 7.9.3.1. Key country dynamics
  - 7.9.3.2. Competitive scenario
  - 7.9.3.3. Regulatory framework
  - 7.9.3.4. Reimbursement structure
  - 7.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.4. Kuwait
  - 7.9.4.1. Key country dynamics
  - 7.9.4.2. Competitive scenario
  - 7.9.4.3. Regulatory framework
  - 7.9.4.4. Reimbursement structure
  - 7.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Key company market share analysis, 2024
8.4. Company Position Analysis
8.5. Company Categorization (Emerging Players, Innovators and Leaders
8.6. Company Profiles
- 8.6.1. GE HealthCare
  - 8.6.1.1. Company overview
  - 8.6.1.2. Financial performance
  - 8.6.1.3. Product benchmarking
  - 8.6.1.4. Strategic initiatives
- 8.6.2. Koninklijke Philips N.V.
  - 8.6.2.1. Company overview
  - 8.6.2.2. Financial performance
  - 8.6.2.3. Product benchmarking
  - 8.6.2.4. Strategic initiatives
- 8.6.3. Siemens Healthineers AG
  - 8.6.3.1. Company overview
  - 8.6.3.2. Financial performance
  - 8.6.3.3. Product benchmarking
  - 8.6.3.4. Strategic initiatives
- 8.6.4. Medtronic
  - 8.6.4.1. Company overview
  - 8.6.4.2. Financial performance
  - 8.6.4.3. Product benchmarking
  - 8.6.4.4. Strategic initiatives
- 8.6.5. Abbott
  - 8.6.5.1. Company overview
  - 8.6.5.2. Financial performance
  - 8.6.5.3. Product benchmarking
  - 8.6.5.4. Strategic initiatives
- 8.6.6. Boston Scientific Corporation
  - 8.6.6.1. Company overview
  - 8.6.6.2. Financial performance
  - 8.6.6.3. Product benchmarking
  - 8.6.6.4. Strategic initiatives
- 8.6.7. Fujifilm Holdings Corporation
  - 8.6.7.1. Company overview
  - 8.6.7.2. Financial performance
  - 8.6.7.3. Product benchmarking
  - 8.6.7.4. Strategic initiatives
- 8.6.8. Zimmer Biomet
  - 8.6.8.1. Company overview
  - 8.6.8.2. Financial performance
  - 8.6.8.3. Product benchmarking
  - 8.6.8.4. Strategic initiatives
- 8.6.9. Nihon Kohden Corporation
  - 8.6.9.1. Company overview
  - 8.6.9.2. Financial performance
  - 8.6.9.3. Product benchmarking
  - 8.6.9.4. Strategic initiatives
- 8.6.10. OMRON Healthcare, Inc.
  - 8.6.10.1. Company overview
  - 8.6.10.2. Financial performance
  - 8.6.10.3. Product benchmarking
  - 8.6.10.4. Strategic initiatives
- 8.6.11. Invacare Corporation
  - 8.6.11.1. Company overview
  - 8.6.11.2. Financial performance
  - 8.6.11.3. Product benchmarking
  - 8.6.11.4. Strategic initiatives

한글목차

의료용 전기 및 전기 치료 기구 시장 성장과 동향

의료용 전기 및 전기 치료 기구 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 의료용 전기 및 전기 치료 기구 시장 변수, 동향, 범위

제4장 의료용 전기 및 전기 치료 기구 시장 : 제품별, 추정·동향 분석

제5장 의료용 전기 및 전기 치료 기구 시장 : 용도별, 추정·동향 분석

제6장 의료용 전기 및 전기 치료 기구 시장 : 최종 용도별, 추정·동향 분석

제7장 의료용 전기 및 전기 치료 기구 시장 : 제품, 용도, 최종 용도에 의한 지역별, 추정·동향 분석